cellular therapy Glendale: does this mean a joint shot?

What can I do today?

Try easy walking or a joint motion that has helped before. Don't force a move that feels sharp or makes you limp.

Cold may calm a joint after use, while warmth can ease morning stiffness. Use whichever feels better, and protect your skin from either extreme.

A cane, brace, pain cream, or medicine patch may make moving easier when soreness gets in the way of dressing, cooking, walking, or sleeping. Check either skin treatment with your doctor because your other medicines still matter.

When is soreness more than ordinary wear?

An ache that builds after use often comes with aging, old injury, or years of strain. You don't have to ignore it when daily jobs keep getting harder.

Fever along with joint heat and swelling calls for prompt care. If a fall leaves you unable to stand, get an exam.

For soreness that stays, note when it begins and what eases it. That gives the person examining you more help than one soreness number.

What comes after home care?

An exam checks the joint's movement, strength, swelling, and sore areas. An X-ray may help when its result could change what you do next.

QC Kinetix offers one free first meeting and regenerative treatment options, which are joint shots made from your blood or same-day marrow and given without surgery by its medical providers. You can consider them after the exam.

Relief isn't certain, and the same care won't fit every joint. Have the office name the shot's contents, recovery time, and choices if soreness stays.

Sources

1. The OARSI non-surgical management guideline evaluated 60 interventions with GRADE methodology and built its recommendations around core treatments - structured exercise, weight management and self-management education - for every patient with knee osteoarthritis, regardless of what else is added.

   Bannuru RR, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

2. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.

3. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.

4. Global Burden of Disease data show osteoarthritis age-standardised prevalence rose 9.3 percent between 1990 and 2017 and years lived with disability rose 9.6 percent, with prevalence higher in women and rising with age.

   Safiri S, et al. — Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis, 2020. DOI: 10.1136/annrheumdis-2019-216515.